Deferred Tax Assets, Valuation Allowance of LIGAND PHARMACEUTICALS INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
LIGAND PHARMACEUTICALS INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • LIGAND PHARMACEUTICALS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $48,331,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $48,331,000 -$7,318,000 -13% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q4 2024 $55,649,000 -$2,050,000 -3.6% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q4 2023 $57,699,000 +$227,000 +0.4% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $57,472,000 +$21,541,000 +60% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $35,931,000 +$11,073,000 +45% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $24,858,000 -$116,480,000 -82% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q4 2019 $141,338,000 +$136,862,000 +3058% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 $4,476,000 -$2,511,000 -36% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $6,987,000 -$8,362,000 -54% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $15,349,000 +$6,283,000 +69% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q4 2015 $9,066,000 -$231,354,000 -96% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q4 2014 $240,420,000 -$9,050,000 -3.6% 31 Dec 2014 10-K 14 Nov 2016 2015 FY
Q4 2013 $249,470,000 -$5,400,000 -2.1% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q4 2012 $254,870,000 +$41,768,000 +20% 31 Dec 2012 10-K/A 12 Dec 2014 2013 FY
Q4 2011 $213,102,000 31 Dec 2011 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.